Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Feb 22 2025

· Issued by Zydus Lifesciences Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-feb-22-2025-1

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated February 22, 2025, titled "Zydus receives final approval from USFDA for Ibuprofen and Famotidine Tablets, 800 mg/26.6 mg".

View Attachment

6ix hasn’t read this filing yet.

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases